


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.59%
-2.58%
+8.85%
-1.56%
+8.59%
TMO
Thermo Fisher
$608.02
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Expands stock buyback program
TMO Price Performance
$579.45 (+4.93%)
$564.88 (+7.64%)
$492.6 (+23.43%)
$532.64 (+14.15%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity

Expands stock buyback program
Future
Future

Earnings are forecast to grow
![]()
TMO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
TMO Street Sentiment is extremely bullish but have mixed views on the near-term outlook
TMO has Low risk level

Average key support and resistance price levels
TMO
Thermo Fisher
608.02
-2.55%
ANVS
Annovis Bio
3.04
+4.83%
ANET
Arista Networks
150.15
+2.36%
PEN
Penumbra
359.03
-0.10%
EXFY
Expensify Inc.
1.46
-2.67%
What is TMO current stock price?
What are TMO stock strengths?
What is TMO Risk Level?
What is TMO market cap and volume?
What is TMO current Stock IQ?
Should I buy TMO stock right now?
Is TMO a Strong Buy right now?
What does a 'Strong Buy' rating mean for TMO?
What does a 'Strong Sell' rating mean for TMO?
What factors influence TMO's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-1.59%
-2.58%
+8.85%
-1.56%
+8.59%
TMO
Thermo Fisher
Current Price
$608.02
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Expands stock buyback program
Recently Viewed
TMO
Thermo Fisher
608.02
-2.55%
ANVS
Annovis Bio
3.04
+4.83%
ANET
Arista Networks
150.15
+2.36%
PEN
Penumbra
359.03
-0.10%
EXFY
Expensify Inc.
1.46
-2.67%

TMO Price Performance
$579.45 (+4.93%)
$564.88 (+7.64%)
$492.6 (+23.43%)
$532.64 (+14.15%)
TMO Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity

Expands stock buyback program
Future
Future

Earnings are forecast to grow
![]()
TMO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
TMO Street Sentiment is extremely bullish but have mixed views on the near-term outlook
TMO has Low risk level

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Dec 30, 2025
Price Target Raised
Buy
BofA
Dec 12, 2025
Initiate
Buy
Morgan Stanley
Dec 12, 2025
Upgrade
Buy
Citigroup
Dec 10, 2025
Initiate
Buy
Goldman Sachs
Dec 09, 2025
Upgrade
Overweight
KeyBanc
TMO Stock IQ
TMO Latest Analysis
A Glimpse of Thermo Fisher Scientifics Earnings Potential. Thermo Fisher Scientific (NYSE:) is gearing up to announce its quarterly earnings on Thursday 2026-01-29. Here'.s a quick overview of what investors should know before the release.Analysts are estimating that Thermo Fisher Scientific will report an The market awaits Thermo Fisher Scientific'.s announcement with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.It'.s important for n
Wed Jan 28, 2026
BlackRock Thermo Fisher And More On CNBCs Final Trades. On CNBC'.s “.Halftime Report Final Trades”. ) as his final trade.BlackRock on Jan. 15 reported better-than-expected fourth-quarter financial results and raised its quarterly dividend. Revenue grew 23% year-over-year (Y/Y) to $7.01 billion beating the consensus of $6.69 billion. Adjusted operating income rose 22% Y/Y to $2.85 billion. Adjusted EPS increased 10% Y/Y to $13.16 beating the consensus of $12.25.
Tue Jan 27, 2026
Countdown to Thermo Fisher (TMO) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS. Looking beyond Wall Streets top-and-bottom-line estimate forecasts for Thermo Fisher (TMO) delve into some of its key metrics to gain a deeper insight into the companys potential performance for the quarter ended December 2025.
Mon Jan 26, 2026
$1000 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth This Much Today. Thermo Fisher Scientific (NYSE:) has outperformed the market over the past 20 years by 6.94% on an annualized basis producing an average annual return of 15.74%. Currently Thermo Fisher Scientific has a market capitalization of $236.24 billion.
Fri Jan 23, 2026
Can Specialty Diagnostics Strength Drive Thermo Fishers Q4 Earnings?. TMO heads into Q4 earnings with Specialty Diagnostics growth fresh FDA approvals and launches that could lift results on Jan. 29.
Fri Jan 23, 2026
Thermo Fisher Scientific (TMO) Reports Next Week: Wall Street Expects Earnings Growth. Thermo Fisher (TMO) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Thu Jan 22, 2026
Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now?. TMO ramps up acquisitions and product launches to drive growth but heavy debt and currency headwinds raise questions for long-term holders.
Wed Jan 14, 2026
Thermo Fisher Scientific Inc. (TMO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.
Tue Jan 13, 2026
TetraScience annonce sa collaboration avec Thermo Fisher Scientific pour accélérer lexploitation des données scientifiques et de lIA dans les laboratoires. Les deux entreprises travailleront ensemble pour aider les organisations pharmaceutiques à améliorer leur efficacité et à obtenir de meilleurs résultats pour les patients. BOSTON 13 janvier 2026 /PRNewswire/ -- TetraScience société spécialisée dans les données scientifiques et lIA a...
Tue Jan 13, 2026
Thermo Fisher Scientific And NVIDIA Partner To Advance AI-Powered Laboratory Automation . (RTTNews) - Thermo Fisher Scientific Inc. (TMO) announced a strategic collaboration with NVIDIA to accelerate the adoption of AI-based solutions and laboratory automation at scale. By combining Thermo Fishers expertise in scientific instruments and lab software with NVIDIAs adv
Tue Jan 13, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.